Expression and biochemical characterization of human immunodeficiency virus type 1 nef gene product. 1990

J Kaminchik, and N Bashan, and D Pinchasi, and B Amit, and N Sarver, and M I Johnston, and M Fischer, and Z Yavin, and M Gorecki, and A Panet
Biotechnology General, Israel Ltd., Kiryat Weizmann, Rehovot.

nef genes from human immunodeficiency virus type 1 isolates BH10 and LAV1 (lymphadenopathy-associated virus type 1) were expressed in Escherichia coli under the deo operon promoter. The two proteins found in the soluble compartment of the bacterial lysate were purified by ion-exchange column chromatography to apparent homogeneity. Determination of the amino-terminal sequence revealed glycine as the first amino acid in the Nef protein, indicating removal of the initiator methionine during expression in E. coli. Under native conditions, the recombinant Nef protein is a monomer of 23 kilodaltons. In denaturing polyacrylamide gels, however, BH10 and LAV1 Nef proteins migrate as 28 and 26 kilodaltons, respectively. GTP binding and GTPase activity were monitored during Nef protein purification. These activities did not copurify with the recombinant Nef protein from either the BH10 or the LAV1 isolate. Purified recombinant BH10 Nef protein was used as an immunogen to elicit mouse monoclonal antibodies. A series of monoclonal antibodies were obtained which reacted with sequences at either the amino or carboxy terminus of Nef. In addition, a conformational epitope reacting with native BH10, but not LAV1, Nef was isolated.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010449 Peptide Mapping Analysis of PEPTIDES that are generated from the digestion or fragmentation of a protein or mixture of PROTEINS, by ELECTROPHORESIS; CHROMATOGRAPHY; or MASS SPECTROMETRY. The resulting peptide fingerprints are analyzed for a variety of purposes including the identification of the proteins in a sample, GENETIC POLYMORPHISMS, patterns of gene expression, and patterns diagnostic for diseases. Fingerprints, Peptide,Peptide Fingerprinting,Protein Fingerprinting,Fingerprints, Protein,Fingerprint, Peptide,Fingerprint, Protein,Fingerprinting, Peptide,Fingerprinting, Protein,Mapping, Peptide,Peptide Fingerprint,Peptide Fingerprints,Protein Fingerprint,Protein Fingerprints
D002850 Chromatography, Gel Chromatography on non-ionic gels without regard to the mechanism of solute discrimination. Chromatography, Exclusion,Chromatography, Gel Permeation,Chromatography, Molecular Sieve,Gel Filtration,Gel Filtration Chromatography,Chromatography, Size Exclusion,Exclusion Chromatography,Gel Chromatography,Gel Permeation Chromatography,Molecular Sieve Chromatography,Chromatography, Gel Filtration,Exclusion Chromatography, Size,Filtration Chromatography, Gel,Filtration, Gel,Sieve Chromatography, Molecular,Size Exclusion Chromatography
D002852 Chromatography, Ion Exchange Separation technique in which the stationary phase consists of ion exchange resins. The resins contain loosely held small ions that easily exchange places with other small ions of like charge present in solutions washed over the resins. Chromatography, Ion-Exchange,Ion-Exchange Chromatography,Chromatographies, Ion Exchange,Chromatographies, Ion-Exchange,Ion Exchange Chromatographies,Ion Exchange Chromatography,Ion-Exchange Chromatographies
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D003488 Cyanogen Bromide Cyanogen bromide (CNBr). A compound used in molecular biology to digest some proteins and as a coupling reagent for phosphoroamidate or pyrophosphate internucleotide bonds in DNA duplexes. Bromide, Cyanogen
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D006160 Guanosine Triphosphate Guanosine 5'-(tetrahydrogen triphosphate). A guanine nucleotide containing three phosphate groups esterified to the sugar moiety. GTP,Triphosphate, Guanosine
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal

Related Publications

J Kaminchik, and N Bashan, and D Pinchasi, and B Amit, and N Sarver, and M I Johnston, and M Fischer, and Z Yavin, and M Gorecki, and A Panet
May 1992, European journal of biochemistry,
J Kaminchik, and N Bashan, and D Pinchasi, and B Amit, and N Sarver, and M I Johnston, and M Fischer, and Z Yavin, and M Gorecki, and A Panet
May 1996, [Hokkaido igaku zasshi] The Hokkaido journal of medical science,
J Kaminchik, and N Bashan, and D Pinchasi, and B Amit, and N Sarver, and M I Johnston, and M Fischer, and Z Yavin, and M Gorecki, and A Panet
October 1991, Virology,
J Kaminchik, and N Bashan, and D Pinchasi, and B Amit, and N Sarver, and M I Johnston, and M Fischer, and Z Yavin, and M Gorecki, and A Panet
November 1994, The Journal of general virology,
J Kaminchik, and N Bashan, and D Pinchasi, and B Amit, and N Sarver, and M I Johnston, and M Fischer, and Z Yavin, and M Gorecki, and A Panet
October 2008, Journal of virology,
J Kaminchik, and N Bashan, and D Pinchasi, and B Amit, and N Sarver, and M I Johnston, and M Fischer, and Z Yavin, and M Gorecki, and A Panet
March 1994, The Journal of general virology,
J Kaminchik, and N Bashan, and D Pinchasi, and B Amit, and N Sarver, and M I Johnston, and M Fischer, and Z Yavin, and M Gorecki, and A Panet
October 1999, Journal of virology,
J Kaminchik, and N Bashan, and D Pinchasi, and B Amit, and N Sarver, and M I Johnston, and M Fischer, and Z Yavin, and M Gorecki, and A Panet
August 1993, Journal of virology,
J Kaminchik, and N Bashan, and D Pinchasi, and B Amit, and N Sarver, and M I Johnston, and M Fischer, and Z Yavin, and M Gorecki, and A Panet
July 2003, FEBS letters,
J Kaminchik, and N Bashan, and D Pinchasi, and B Amit, and N Sarver, and M I Johnston, and M Fischer, and Z Yavin, and M Gorecki, and A Panet
October 2010, Molecular aspects of medicine,
Copied contents to your clipboard!